Needham Reiterates Buy on Merit Medical Systems, Maintains $96 Price Target
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Mike Matson has reiterated a 'Buy' rating on Merit Medical Systems (NASDAQ:MMSI) and maintained a price target of $96.
July 26, 2023 | 9:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Mike Matson has reiterated a 'Buy' rating on Merit Medical Systems and maintained a price target of $96.
The reiteration of a 'Buy' rating by a respected analyst like Mike Matson is a positive signal for Merit Medical Systems. The maintained price target of $96 indicates that the analyst believes the stock has significant upside potential. This could lead to increased investor interest and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100